Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry
about
Inflammatory breast cancer: New factors contribute to disease etiology: A reviewRacial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer modelsAldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer.International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentSurvival of women with inflammatory breast cancer: a large population-based studyAssociation of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.Biological markers and response to neoadjuvant taxane-based chemotherapy in patients with locally advanced breast cancer.Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancerNeoadjuvant Treatment in Patients with HER2-Positive Breast Cancer.Anticipatory activation of the unfolded protein response by epidermal growth factor is required for immediate early gene expression and cell proliferation.Role of epidermal growth factor receptor in breast cancer.Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.Advances in systemic therapy for metastatic breast cancer: future perspectives.Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.Inflammatory breast cancer in the Netherlands; improved survival over the last decades.Lymph node status in inflammatory breast cancer.Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET/CT.How do I treat inflammatory breast cancer?HER2-directed T-cell receptor-mimicking antibody: a "Me Too" or an example of novel antitumor aggressive mimicry?Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with 177Lu.Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
P2860
Q27027856-6106330B-2343-49B0-899F-AFE07721ED9EQ30823443-5A63E6A9-FB3E-4BFA-8567-89863E93F07CQ33770856-D5E35AF2-168F-4FD2-9ACB-81A92CE9905CQ33870504-0CEF203C-E840-4DE1-94F7-D2BF6876FA31Q33946233-A9105D2F-1C62-48B3-A8A7-15EA6B67E18AQ35017523-F5938C34-2CD1-4BAE-A1A5-8D6655D7AE46Q35608330-28535FC2-A56A-436B-B09D-4D02E0F4EC7CQ35681702-918025FB-E735-453B-AEAB-4ED93298C2E3Q36505849-1120B7EE-5084-40DD-9A04-FCF1BE4330D1Q36578574-179D5BEF-820C-4525-B15E-90CD1F5ACEB7Q36914142-7A3EFAA7-4575-4CD4-A2AA-1E919779062BQ37033459-8DF64F0D-52C9-4776-86C2-0DC17FD14BDBQ37320346-400D0911-DC03-440E-BA35-CBD40F6B5944Q37690619-AE7FCA9C-3E2F-4D7B-B025-6B7DEEEFA5BBQ38681576-645F5309-198F-4156-A2D5-DAB1C2313AFFQ39126801-F0D91F9E-3C6C-48F9-BDF0-AF4D249B1D93Q40358255-7182DA19-8925-49C1-BE4A-1C2EF63B4E07Q41110592-5CC9EAD2-D340-4B06-8EC0-84D5377E05B3Q41507039-6770D74B-7D35-4A92-8D0D-A237E3EDDBAEQ44586994-7F2F1C60-9C9C-4AB7-851B-4402622FA3CBQ45741660-59B219BA-83E9-4E7C-AC07-4B35157DAC61Q51023485-8F6CB448-071F-4815-A8EF-C90CAB98A774Q52775601-E4439FC4-D27E-45FE-A04C-F5B7C89E7A0CQ54281598-299BC741-D14C-49C4-9246-EA2D71F123FD
P2860
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic impact of human epi ...... the California Cancer Registry
@en
Prognostic impact of human epi ...... he California Cancer Registry.
@nl
type
label
Prognostic impact of human epi ...... the California Cancer Registry
@en
Prognostic impact of human epi ...... he California Cancer Registry.
@nl
prefLabel
Prognostic impact of human epi ...... the California Cancer Registry
@en
Prognostic impact of human epi ...... he California Cancer Registry.
@nl
P2093
P2860
P921
P356
P1476
Prognostic impact of human epi ...... the California Cancer Registry
@en
P2093
Jason A Zell
Rita S Mehta
Thomas H Taylor
Walter Y Tsang
P2860
P2888
P356
10.1186/BCR2225
P577
2009-02-19T00:00:00Z
P5875
P6179
1026378344